Ein möglicher Fall von Brodalumab-induzierter Ichthyose.
作者信息
Mantovani Lucia, Schenetti Cecilia, Montinari Elena, Pacetti Lucrezia, Schettini Natale, Borghi Alessandro, Corazza Monica
机构信息
Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.
Section of Anatomic Pathology, Department of Diagnostic Imaging and Experimental Medicine, University of Ferrara S. Anna Hospital, Ferrara, Italy.
出版信息
J Dtsch Dermatol Ges. 2023 Mar;21(3):288-290. doi: 10.1111/ddg.14976_g.
PMID:36929544
Abstract
摘要
相似文献
1
Ein möglicher Fall von Brodalumab-induzierter Ichthyose.一种可能由布罗达单抗诱发的鱼鳞病病例。
J Dtsch Dermatol Ges. 2023 Mar;21(3):288-290. doi: 10.1111/ddg.14976_g.
2
[Not Available].[无可用内容]。
J Dtsch Dermatol Ges. 2020 Jan;18(1):17-26. doi: 10.1111/ddg.13968_g.
3
Präzisionsmedizinischer Ansatz bei einem seltenen Fall von autosomal rezessiver kongenitaler Ichthyose.
J Dtsch Dermatol Ges. 2022 Dec;20(12):1651-1654. doi: 10.1111/ddg.14923_g.
4
Ein interessanter Fall: Die Erworbene Hemmkörper-Hämophilie.一个有趣的病例：获得性血友病。
J Dtsch Dermatol Ges. 2019 May;17 Suppl 2:25-27. doi: 10.1111/ddg.13786.
5
The safety of brodalumab for the treatment of psoriasis.巴瑞替尼治疗银屑病的安全性。
Expert Opin Drug Saf. 2020 Apr;19(4):365-372. doi: 10.1080/14740338.2020.1730326. Epub 2020 Feb 21.
6
Brodalumab: A Review in Moderate to Severe Plaque Psoriasis.布罗达芦单抗：治疗中重度斑块状银屑病的研究进展。
Drugs. 2018 Mar;78(4):495-504. doi: 10.1007/s40265-018-0888-4.
7
Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials.布罗达umab 治疗头皮和甲银屑病的疗效：三项 3 期试验结果。
J Dermatolog Treat. 2022 Feb;33(1):261-265. doi: 10.1080/09546634.2020.1749546. Epub 2020 Apr 21.
8
Spotlight on brodalumab in the treatment of moderate-to-severe plaque psoriasis: design, development, and potential place in therapy.聚焦布罗达单抗治疗中度至重度斑块状银屑病：设计、研发及在治疗中的潜在地位
Drug Des Devel Ther. 2017 Jul 7;11:2065-2075. doi: 10.2147/DDDT.S113683. eCollection 2017.
9
Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics.布罗达单抗来救援：布罗达单抗在曾接触过生物制剂或对生物制剂反应不足的银屑病患者中的疗效和安全性
Dermatol Ther (Heidelb). 2020 Aug;10(4):615-621. doi: 10.1007/s13555-020-00411-w. Epub 2020 Jun 12.
10
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life setting.依奇珠单抗与布罗达单抗治疗中重度银屑病的间接比较：一项意大利单中心真实世界回顾性研究的结果
Dermatol Ther. 2022 Sep;35(9):e15667. doi: 10.1111/dth.15667. Epub 2022 Jul 11.
引用本文的文献
1
Analysis and mining of brodalumab adverse events based on FAERS database.基于FAERS数据库的布罗达单抗不良事件分析与挖掘
Sci Rep. 2025 May 25;15(1):18175. doi: 10.1038/s41598-025-03192-4.
2
A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system.一项基于美国食品药品监督管理局不良事件报告系统的关于布罗达单抗的真实世界药物警戒研究。
Sci Rep. 2025 Jan 17;15(1):2346. doi: 10.1038/s41598-025-86976-y.
3
Acquired ichthyosis: a clinical review.获得性鱼鳞病：临床综述。
Arch Dermatol Res. 2023 Nov;315(9):2529-2543. doi: 10.1007/s00403-023-02668-5. Epub 2023 Jul 9.
Zotero 插件